Ian Titus Brenninkmeijer

Pharem Biotech uses its broad biotechnology expertise to develop innovative enzymatic products that provide an effective way of removing organic pollutants in water environments. The products are specifically developed to meet customer needs of a simple and efficient solution to tackle serious environmental challanges within their scope of operation.

We develop a fully flexible pressurized alkaline electrolyser to produce the lowest cost green hydrogen. Our technology can switch on and off following intermittent renewable energy, procuring hydrogen when power prices are low and selling electricity when prices are high.

Ekolution är ett innovativt greentech bolag vars mål är att i alla projekt och i alla steg tänka miljö och klimatpåverkan. Ekolution tillverkar och säljer hållbara biobaserade byggmaterial av industrihampa. Våra material är CO2-negativa, energieffektiva och hälsosamma för både byggnad, människa och planeten. Vår flaggskeppsprodukt Ekolution® Hampafiberisolering är en certifierad byggisolering registrerad på EPD International, CE märkt, Byggvarubedömningen, SundaHus, BASTA mfl. Naturfibrer, och specifikt hampa, kommer sannolikt att spela en stor roll i materialrevolutionen som måste hända i konstruktion och byggnader /// Ekolution is GreenTech company that works to disrupt the construction sector. We are well positioned to lead this development with a range of high-performance, low-cost and certified products. Ekolution manufactures and sells products made from hemp and its flagship hemp fibre insulation is CO2-negative - energy efficient - healthy for both buildings, people and our planet.

Pharem Biotech uses its broad biotechnology expertise to develop innovative enzymatic products that provide an effective way of removing organic pollutants in water environments. The products are specifically developed to meet customer needs of a simple and efficient solution to tackle serious environmental challanges within their scope of operation.

Founded in 1985, Challenger Limited is an ASX-listed investment management company managing $131 billion in assets (as at 31 December 2024). Challenger’s purpose is to provide customers with financial security for a better retirement. To fulfil this purpose, Challenger leverages capabilities across our two core businesses, Life and Funds Management. We offer investment strategies that exhibit consistently superior performance and help customers in retirement with safe and reliable income. For our social media disclaimer statement, visit: http://www.challenger.com.au/Disclaimer

We develop a fully flexible pressurized alkaline electrolyser to produce the lowest cost green hydrogen. Our technology can switch on and off following intermittent renewable energy, procuring hydrogen when power prices are low and selling electricity when prices are high.

At Fidante, we provide investors with access to best-in-class investment managers. We are one of Australia’s largest active investors, offering compelling strategies across equities, fixed income, and alternative assets, via partnerships with leading investment teams. We are a global investment management business and form part of the Challenger Limited Group, an ASX-listed investment management firm.